Yi Ping Rong
Chief Tech/Sci/R&D Officer presso HBM HOLDINGS LIMITED
Patrimonio netto: - $ in data 31/03/2024
Profilo
Yi Ping Rong is currently an Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd.
and an Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd.
Dr. Rong previously worked as a Member at The American Association of Cancer Research.
Dr. Rong holds a doctorate degree from Case Western Reserve University, conferred in 2008, and a graduate degree from East China University of Science & Technology, conferred in 2002.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
HBM HOLDINGS LTD.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Yi Ping Rong
| Società | Posizione | Inizio |
|---|---|---|
| HBM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 05/05/2022 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Director/Board Member | - |
Precedenti posizioni note di Yi Ping Rong
| Società | Posizione | Fine |
|---|---|---|
| The American Association of Cancer Research | Corporate Officer/Principal | - |
Formazione di Yi Ping Rong
| Case Western Reserve University | Doctorate Degree |
| East China University of Science & Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
| The American Association of Cancer Research |
- Borsa valori
- Insiders
- Yi Ping Rong
